Showing results (1-10 of 1,114) with videos related to
Sort By:
Pageof 112
Advances in Immunology|March 1, 2016
Mouse Models of Tumor ImmunotherapyShin Foong Ngiow, Sherene Loi, David Thomas, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapyJohn Stagg, Sherene Loi, Upulie Divisekera, et al.Cancer Cell|April 16, 2015
Radiotherapy complements immune checkpoint blockadeShin Foong Ngiow, Grant A McArthur, Mark J SmythTrends in Immunology|August 20, 2013
A balance of interleukin-12 and -23 in cancerShin Foong Ngiow, Michele W L Teng, Mark J SmythCancer Research|October 20, 2011
Prospects for TIM3-Targeted Antitumor ImmunotherapyShin Foong Ngiow, Michele W L Teng, Mark J SmythOncoimmunology|July 3, 2015
Natural Killer cell control of BRAF mutant melanoma during targeted therapyLucas Ferrari de Andrade, Shin Foong Ngiow, Ludovic Martinet, et al.Cancer Research|May 16, 2015
Classifying Cancers Based on T-cell Infiltration and PD-L1Michele W L Teng, Shin Foong Ngiow, Antoni Ribas, et al.Nature Reviews. Clinical Oncology|November 25, 2015
Combination cancer immunotherapies tailored to the tumour microenvironmentMark J Smyth, Shin Foong Ngiow, Antoni Ribas, et al.Oncoimmunology|July 30, 2013
BRAF-targeted therapy and immune responses to melanomaShin Foong Ngiow, Deborah A Knight, Antoni Ribas, et al.Oncoimmunology|March 26, 2013
The interaction between murine melanoma and the immune system reveals that prolonged responses predispose for autoimmunityShin Foong Ngiow, Bianca von Scheidt, Andreas Möller, et al.Pageof 112